Valuation: Qlife Holding AB

Market Cap 31.13M 3.17M 2.84M 2.61M 2.37M 4.42M 301M 4.5M 12.5M 158M 11.89M 11.64M 499M P/E 2024
-0.26x
P/E 2025 -1.73x
Enterprise Value 44.15M 4.49M 4.02M 3.7M 3.35M 6.27M 427M 6.39M 17.72M 224M 16.87M 16.51M 708M EV / Sales 2024
222x
EV / Sales 2025 178x
Free-Float
100%
Yield 2024 *
-
Yield 2025 -
1 day-1.82%
1 week-2.71%
Current month-23.00%
1 month-23.00%
3 months-44.43%
6 months-43.80%
Current year-62.04%
1 week 0.85
Extreme 0.85
1.11
1 month 0.85
Extreme 0.85
1.64
Current year 0.85
Extreme 0.85
3.09
1 year 0.85
Extreme 0.85
3.8
3 years 0.85
Extreme 0.85
179
5 years 0.85
Extreme 0.85
71,200
10 years 0.85
Extreme 0.85
120,000
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2019
Chief Executive Officer 59 11/10/2019
Director of Finance/CFO 60 01/11/2023
Director TitleAgeSince
Director/Board Member 71 21/03/2025
Chairman 61 21/03/2025
Director/Board Member 52 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
14/6/23 Free

Chief Executive Officer

12,697,080 2.1166%
14/6/23
Qlife ApS
OthersCompany 40,630,656 6.7731%
13/6/23 Free

Chief Financial Officer

5,078,832 0.8466%
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%-2.71%-50.09%-98.25% 3.17M
+1.56%+2.41%-14.82%+14.19% 184B
-6.38%-4.98%-20.90%+11.15% 112B
-0.59%+1.18%+6.12%+37.97% 118B
+3.42%+1.71%-42.32%+9.52% 94.58B
+0.09%-0.05%-3.04%+78.44% 63.13B
-0.46%+0.42%+8.19%+82.97% 55.66B
-0.23%-0.52%+10.31%-21.19% 53.9B
-4.30%-1.64%-12.30%+39.06% 43.42B
+0.58%+2.00%-1.07%-6.43% 34.68B
Average -0.81%-0.22%-11.99%+14.74% 75.93B
Weighted average by Cap. -0.49%+0.23%-10.66%+25.22%

Financials

2024 2025
Net sales 50K 5.09K 4.56K 4.19K 3.8K 7.1K 483K 7.23K 20.07K 254K 19.1K 18.69K 802K 324K 32.98K 29.54K 27.17K 24.62K 46.02K 3.13M 46.88K 130K 1.65M 124K 121K 5.19M
Net income -55.92M -5.69M -5.1M -4.69M -4.25M -7.94M -540M -8.09M -22.45M -284M -21.36M -20.91M -897M -20.56M -2.09M -1.87M -1.72M -1.56M -2.92M -199M -2.97M -8.25M -105M -7.85M -7.69M -330M
Net Debt 5.98M 609K 546K 502K 455K 850K 57.84M 866K 2.4M 30.42M 2.29M 2.24M 95.94M 13.02M 1.33M 1.19M 1.09M 989K 1.85M 126M 1.88M 5.23M 66.21M 4.97M 4.87M 209M
Projected Income Statement - Annual - Qlife Holding AB
Logo Qlife Holding AB
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Employees
2
Date Price Change Volume
30/10/26 SEK 1.078 -1.82% 35,448
29/10/26 SEK 1.098 +6.60% 128,287
28/10/26 SEK 1.030 -0.96% 13,781
27/10/26 SEK 1.040 -0.38% 41,455
26/10/26 SEK 1.044 -5.78% 55,545

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Qlife Holding AB
  1. Stock Market
  2. Stocks
  3. QLIFE Stock